この記事を読む

免疫チェックポイント阻害薬投与直後のソトラシブで肝機能異常重篤化

Severe sotorasib-related hepatotoxicity and non-liver adverse events associated with sequential anti-PD(L)1 and sotorasi…

この記事を読む

ⅠB~ⅢA期への術後オシメルチニブの生存期間延長効果

Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC. Tsuboi M et al.N Engl J Med. 2023 Jun4. Epub ahead of …

この記事を読む

非喫煙者にもCT検診が有効?

Low-Dose Computed Tomography (LDCT) Lung Cancer Screening in Asian Female Never-Smokers Is as Efficacious in Detecting L…

この記事を読む

局所進行胸腺腫の不完全切除例をどうするか

Unradical Surgery for Locally-Advanced Thymoma: Is it time to evolve Perspectives? Mastromarino MG et al.Lung Cancer. Ep…

この記事を読む

血漿T790Mをモニターし、オシメルチニブへ切り替える戦略は有効か?

Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC):E…

この記事を読む

オンコマインかAMOYか、不一致例は何が原因か

Clinical application of the AMOY 9-in-1 panel to lung cancer patients. Kunimasa KLung Cancer. 2023 May;179:107190.PMID: …

この記事を読む

非扁平上皮非小細胞肺癌の標準治療の後

Real-world treatment patterns and outcomes of patients with metastatic nonsquamous non-small cell lung cancer after prog…

この記事を読む

KRAS G12Cに対するソトラシブの2年追跡結果

Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated KRAS G12C-Mutated Non-Smal…

この記事を読む

EGFR遺伝子変異陽性に対するPACIFICレジメン

Durvalumab After Chemoradiotherapy in Unresectable StageⅢ EGFR-Mutant NSCLC: A Post Hoc Subgroup Analysis From PACIFIC. …

この記事を読む

TTF-1別に免疫複合療法もレジメン選択をすべきか?

Clinical Outcomes of Combined Chemoimmunotherapy in Patients With Advanced Lung Adenocarcinoma: A Prospective Observatio…